The Helm
VC Fund
New York, United States
The Helm is a generalist seed-stage fund investing in companies with at least one female founder. We are investing in founders who take a broad view of the needs of the world, and are using technology to create novel, enduring solutions to difficult problems.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries The Helm invests in
Stages The Helm invests in
Countries The Helm invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Investment Focus
Industry
- Health Care 8 (20%)
- Wellness 5 (12%)
- Biotechnology 5 (12%)
- E-Commerce 4 (10%)
- Communities 4 (10%)
Stage
- Seed 17 (41%)
- Funding Round 10 (24%)
- Series A 6 (15%)
- Pre-Seed 1 (2%)
- Series B 1 (2%)
Country
- United States 22 (54%)
- United Kingdom 2 (5%)
- Switzerland 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Julie Weber
Head of External Relations; General Partner; General Partner
|
Head of External Relations; General Partner; General Partner | Total investments: 0 | Find email | |
Lauren Kang
Founding member
|
Founding member | Total investments: 3 | Find email | |
Lindsey Taylor Wood
Founder, CEO & GP; Founder, CEO & General Partner
|
Founder, CEO & GP; Founder, CEO & General Partner | Total investments: 2 | Find email | |
Olivia Fleming
Head of Content and Venture Partner
|
Head of Content and Venture Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Biographica
|
Biographica is a computational biology company that develops software tools and platforms to support genomic data analysis, interpretation, and visualization for research and clinical applications. Its solutions are designed to help scientists, clinicians, and bioinformaticians process complex genomic datasets, annotate genetic variants, andexplore biological insights through integrated workflows and interactive visualizations. The company’s platform combines data management, algorithmic analysis, and graphical interfaces to streamline tasks such as sequence alignment, variant calling, functional interpretation, and cohort comparison. Biographica’s tools support interoperability with common bioinformatics formats and pipelines, enabling users to integrate genomic workflows with existing research infrastructure. The company also provides APIs and developer tools to allow custom integration, automation, and extension of analytic capabilities within broader computational environments. Its offerings are used across life sciences research, translational projects, and precision medicine initiatives that require scalable, interpretable genomic data analysis. | $9.5M / Seed / Jan 07, 2026 | |
Simplifyber
|
Simplifyber is changing the way clothes are created, transforming the world's $1.5 trillion Apparel Industry and 250-year old factory system into sustainable, additive manufacturing. By assembling clothes with chemistry rather than with sewing machines, the Simplifyber process eliminates much of the waste, carbon emissions, and water pollutionthat have led to fashion’s devastating environmental and social impact in recent years. Efficient, plant-based and closed-loop, Simplifyber is revolutionizing the way the world manufactures clothing with its proprietary technology and cutting-edge techniques. | $12M / Series A / Apr 10, 2025 | |
itselectric
|
Itselectric is a curbside EV charging system designed especially for urban areas and to advance the adoption of electric vehicles. They increased access to public charging, which encourages the adoption of EVs and leads to cleaner air and healthier communities. | $6.5M / Seed / Jul 16, 2024 | |
Testmate Health
|
Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home. | $6M / Seed / May 02, 2024 | |
Wthn
|
Wthn is a natural wellness brand offering herbal medicine & acupuncture treatments.The brand makes acupuncture and herbs accessible to everyone and aims to demystify and educate its clients around the benefits of natural healing. Its mission is to help others heal their bodies and relax their minds in order to lead happier, healthier, andmore fulfilled lives every day by stimulating and unlocking the body’s natural healing defenses.Michelle Larivee and Shari Auth founded the brand in New York, New York in 2017. | $5M / Series A / Jan 08, 2024 | |
Sway
|
Sway offers regenerative design solutions for plastic pollution using seaweed to create compostable replacements for single-use plastics. The company was co-founded by Julia Marsh, Matt Mayes, and Leland Maschmeyer and is headquartered in San Francisco, California, United States. | $5M / Seed / Dec 05, 2023 | |
AOA
|
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M / Oct 11, 2023 | |
|
AOA
|
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that willimprove clinical practice and help reduce patient mortality. | $17M / Series A / Oct 11, 2023 | |
OneRoof
|
OneRoof connects people living in the same building to form a resourceful, fun, and supportive neighbor community. The company was founded in 2020 and is headquartered in Brooklyn, New York. | $3.2M / Seed / Jan 05, 2023 | |
Hey Jane
|
Hey Jane is a telehealth startup that connects patients to healthcare providers that offer online medical consultations. The company's innovative Complete Care model utilizes technology for unparalleled layers of support: medical, emotional, and social. Since 2021, Hey Jane has helped nearly 20,000 patients get the care they need. And this isonly the beginning; soon, we will reimagine care for even more common but underserved treatments, with the ultimate goal of becoming the most trusted healthcare company out there—one that pushes the boundaries of access with convenient, inclusive, and patient-driven care. | $6.1M / Venture - Series Unknown / Oct 19, 2022 | |
| See all 41 investments → | |||
Co-Investors
Fitz Gate Ventures
5 deals together
Techstars
5 deals together
Backstage Capital
4 deals together
Gaingels
4 deals together
Muse Capital
4 deals together
XFactor Ventures
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does The Helm invest in?
The Helm invests primarily in Health Care, Wellness and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 41 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact The Helm?
Public channels for The Helm include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at The Helm?
The team at The Helm includes Julie Weber (Head of External Relations; General Partner; General Partner), Lauren Kang (Founding member) and Lindsey Taylor Wood (Founder, CEO & GP; Founder, CEO & General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
